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ABSTRACTS 
lA 
Abstracts of Original Contributions: Young Investigators 
Awards Competition 
The purpose of the Awards is to find and encourage the young 
investigators of promise on whom the future of cardiology de· 
pends. Any physician/scientist who is currently in a residency or 
fellowship training program or who has been in such a program 
within the past three years is eligible to submit an original 
investigation. Medical students and PhD candidates are also 
eligible for the competition. 
The Judging Committee will select at the Young Investigators 
Awards Competition a finalist and a runner·up for each of the 
following categories: a) Clinical Investigations; b) Physiology, 
Pharmacology and Pathology; and c) Molecular and Cellular 
853 1992 Young Investigators Awards Competition 
Monday, April \3, 1992 
10:30 AM-Noon 
Dallas Convention Center 
Room W107 
853·1 10:30 
SYSTOUC DYSFUNCl10N AND DECREASED AVAILABILI1Y 
OF ACTIVATOR CALCIUM IN HAMSTERS WITH END· 
STAGE HEART FAILURE. LA. Bentivegna, S.E. Litwin, A.J. 
Zeind, J.P. Morgan, Harvard Medical School, Boston, MA 02215. 
We correlated changes in hemodynamic function with intracellular 
calcium (Cal,;) in the BIO-TO.2 cardiomyopathic hamster with late 
heart failure. Results from LV catheterization indicate that this 
strain of hamster has severe systolic dysfunction but normal end•
diastolic pressure. Data obtained in isolated, buffer-perfused 
hearts loaded with the Ca" indicator, aequorin identify a primary 
deficit of activator calcium that correlates with a decreased rate 
of pressure development (+dP/dt) and a marked inability to 
generate normal peak systolic pressures. Peak systolic [Ca"]; was 
0.6S±0.OS 11M in the control and 0.44±0.02 11M in 
cardiomyopathic hearts (p<0.05). In contrast, rCa"~]; at end•
diastole did not Significantly differ between control and 
cardiomyopathic hearts: 0.28±0.03 11M versus 0.37±0.09 11M, 
respectively. 
Upon addition of calcium to the coronary perfusate of 
myopathic hearts, neither LV pressure, nor rCa"~], were corrected 
to the control values; moreover, the rate ofrelaxation (-dP/dt) was 
decreased and the Ca"; transient prolonged in the myopathic 
hearts compared to the controls. These findings are consistent 
with significant impairment of sarcoplasmic reticular function 
during this late stage of heart failure. 
CONCLUSION: The BIO TO.2 strain of hamster with late-stage 
heart failure demonstrates a disproportionate impairment of 
systolic versus diastolic function and may be particularly useful for 
studying the pathogenesis and treatment of chronic systolic failure 
in man that is due to abnormal Ca"; modulation. 
Cardiology. The awards will be presented at the 41st Annual 
Convocation Ceremony on Wednesday, April 15, at 6:00 p.m. 
The Young Investigator of the Year for each category will 
receive a plaque, a certificate and $2,000. The runners·up will 
each receive $500 and a certificate. 
The Amercian College of Cardiology Young Investigators 
Awards Competition is supported by a grant from Searle. 
Douglas P. Zipes, MD, FACC 
Chairman 
1992 Young Investigators Awards Competition 
853·2 10:45 
ASCORBYL FREE RADICAL AS A REAL·TIME MARKER OF 
OXIDATIVE MYOCARDIAL STRESS: AN ELECTRON PARA•
MAGNETIC RESONANCE STUDY. Mukesh K. Sharma, M.D., 
Garry R. Buettner, Ph.D., and Richard E. Kerber, M.D., FACC, 
Cardiovascular Division, University of Iowa, Iowa City, IA 52242 
Current approaches to measure free radical production during 
coronary occlusion/reperfusion sequences use spin-traps and 
are not real-time. We have used the ascorbyl free radical (AFR) 
as a new quantitative real-time marker of oxidative stress, Le., 
free radical generation, during reperfusion. Twelve open-chest 
dogs underwent left anterior descending artery occlusion for 
either 5 min (Group A, n=5) or 20 min (Group B, n=7) followed 
by 30 min of reperfusion. Ascorbic acid (3.8-15.2 mg/min) was 
infused intravenously to maintain constant systemic ascorbate 
levels. Blood from the great cardiac vein was shunted through 
an electron paramagnetic resonance (EPR) spectrometer. The 
concentration of AFR in coronary venous blood was monitored 
by continuous EPR scans. RESULTS: Baseline AFR was similar 
_ in both groups (A=6.7±SD1.8 nM, 
__ • B=5.9±1.9 nM; p=ns). AFR rose 
l .';;::-' markedly in each animal upon 
; • i'1.~ reperfuslon with the overall rise 
II • • ~ being significantly higher in Group ..... -1.. B (p=O.03). The time to maximum 
'I].... AFR concentration upon reper-
.. , fusion was longer in Group B 
(5.B±1.6 vs. 3.4±O.8 min; p<O.05). 
'· ......... ·.1 -- Post-reperfusion LV dysklnesis 
was observed by 2-D echo only in group B. CONCLUSIONS: 1) 
On-line measurement of free radical generation is feasible by 
using AFR as a marker. 2) The rise in AFR concentration was 
greater after longer coronary occlusion and was accompanied 
by LV dyskinesis. This is the first real-time measurement of 
free radical generation in an intact animal model. 
2A ABSTRACTS 
853·3 
PARACRINE REGULATION OF FIBROBLAST GROwrn 
FACTOR EXPRESSION: POTENTIAL MECHANISM FOR 
REGULATING MYOGENIC DIFFERENTIATION. 
Jonathan C. Fox, MD, PhD and Judith L. Swain, MD, Duke 
University Medical Center, Durham, NC 27710. 
Fibroblast growth factors (FGFs) are potent inhibitors of 
myogenic differentiation. The recent observation that the 
endogenous expression of acidic and basic FGF by myogenic 
cells decreases coordinately with differentiation suggests a 
regulatory role for these growth factors in myogenesis. Since 
other proteins known to influence myogenesis (e.g. MyoDI 
and myogenin) activate their own expression as well as the 
expression of other members of their family, we hypothesized 
that the FGFs might be capable of similar autoregulation. We 
examined the effect of exogenously supplied FGF on the 
abundance of the mRNAs encoding acidic and basic FGF in 
Sol 8 myoblasts, and demonstrate that both acidic and basic 
FGF stimulate the accumulation of the mRNAs encoding these 
FGFs. Autoregulation of FGF expression was also supported 
by the finding that inhibition of endogenously expressed acidic 
FGF (using antisense RNA) suppresses the accumulation of 
basic FGF mRNA. Thus FGFs can auto and transregulate 
their own expression in a manner analogous to that observed 
for the myogenic determination proteins. In addition, similar 
to that previously observed for MyoDI, both acidic and basic 
FGF suppress myogen in expression in myoblasts. These 
results suggest two mechanisms whereby endogenously 
produced FGFs participate in the maintenance of the 
undifferentiated state of myogenic cells, and provide support 
for both autocrine and paracrine roles for FGF in the 




MOLECULAR SIGNALS UNKING MYOGENIC DIFFERENTIATION 
AND CELL CYCLE WITHDRAWL: TRANSCRIPTIONAL 
REGULATION OF THE MYOGLOBIN PROMOTER BY THE P53 
ANTI-ONCOGENE. Richard H. Karas M.D .• Ph.D .. Christian Grohe 
M.D .. R Sanders Williams M.D. FACC. Division of Cardiology. 
University of Texas. Southwestern Medical Center. Dallas. Tx. 
75235. 
The Inability of cardlomyocytes to regenerate following 
myocardial Infarction can lead to congestive cardiomyopathy. 
The molecular signals which prevent re-entry Into the cell cycle 
following terminal differentiation In myocytes Is unknown. 
Recent studies have suggested that the myogenic determination 
gene MyoD which Induces differentiation In skeletal myocytes 
may Interfere with cellular proliferation by activating the p53 
anti-oncogene. and that p53 may also activate expression of a 
muscle-specific gene (creatine kinase). We have investigated the 
elTect of p53 on MyoD Induced expression of the muscle-specific 
gene myoglobin (Mb) In tissue culture experiments. Activator 
plaSmlds driving expression of either MyoD or p53 and reporter 
plaSmlds In which luclferase expression Is driven by either of 2 
different constructs of the human myoglobin (Mb) promoter were 
transfected by eleclroporatlon Into a fibroblast derived cell line 
(C3HIOTI/2) lhat Is known to be converted to a myogenic lineage 
by forced expression of MyoD. MyoD Induced expression of 
luclferase driven by the Mb promoter by 6 to IO-fold. Co•
transfecllon of p53 prcvented the transactlvatlon of the Mb 
promoter by MyoD. redUCing expression 10 baseline levels. The 
inhibitory elTect of p53 was seen with both reporter constructs. 
but was not seen In another cell line' (HeLa) which does not 
undergo myogeniC conversion In response to MyoD. Forced 
expression of a dllTerent anti-oncogene (Retinoblastoma) had no 
elTect on Mb expression. Control experiments indicate that Mb 
transcription was not Ilmlted by promoter competition or by non•
specific tOXIc elTects of p53. We conclude that p53 reduces Mb 
expression by acting as a transcriptional regulator. and that the 
repertOire of biologic effects of p53 Includes regulation of 
expression of cellular genes In addition to prevention of cell 
cycling. 
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DETERMINANTS OF INFARCT SIZE IN REPERFUsION THERAPY FOR 
ACUTE MYOCARDIAL INFARCTION 
Timothy Christian MD FACC, Robert Schwartz MD FACC, 
Raymond Gibbons MD FACC. Mayo Clinic, Rochester, MN 55905 
The purpose of this study was to determine the relation•
ship of myocardium at risk (MAR), collateral circulation, 
and time to reperfusion (TIME) with infarct size (IS) in 
89 patients with acute myocardial infarction. All pts had 
successful reperfusion (confirmed by angiography) with 
either IV thrombolysis (32 pts) or direct coronary angio•
plasty (57 pts) within 24 hours (4.7 ± 3.9 hours, 
range: 0.5-21.5 hours). Tomographic imaging with Tc-99m 
sestamibi was performed acutely to determine MAR and at 
discharge to determine IS using previously described 
methods. Angiographic collaterals (COll) were graded 
o (no collaterals) to 3 (filling of entire vessel). 
Collateral flow was also assessed noninvasively by 
analyzing the depth of the acute sestamibi count profile 
curves. Nadir, defined as minimum counts/maximum counts, 
was significantly (p=0.006) associated with COll_ MAR, 
COll, and nadir were all univariately associated with IS, 
but TIME was not. The relationship of COll and nadir to 
IS was dependent on infarct location (anterior vs 
inferior). Multivariate analysis was performed to examine 
independent predictors of IS using COll(#I) or Nadir(#2): 
Model #1 f ~ Model #2 f ~
MAR ~ <~ MAR ~  
COll 7.2 0.0005 Nadir 21.8 <0.0001 
COll x location 4.8 0.003 Nadir x location 10.1 0.002 
TIME 4.5 0.04 TIME 6.6 0.01 
R2=0.70 R2=0.59 
Conclusion: MAR, TIME, and collateral circulation are 
independent predictors of IS and account for most of its 
variability. Ideally, all three parameters should be 
examined when evaluating new reperfusion strategies. 
853·6 11:45 
Impaired Endothelium·Dependent Pulmonary Arterial 
Responses In Heart Failure: Influence Of Pulmonary 
Hypertension 
Thomas Porter, David Taylor. Alan Cycan, Cynthia Bagley. Pramod 
Mohanty. McGuire VA Med. Ctr. and Med. Coli. of VA. Richmond. 
VA 
Although post-caplilary pulmonary hypertension (PH) is frequently 
observed in left sided heart failure (HF), the vascular mechanisms 
related to its development are unclear. Recently, endothelium•
dependent abnormalities have been observed in isolated 
pulmonary arterial (PA) rings of patients with primary lung disease. 
However. in vivo determination of endothelium-dependent 
pulmonary arterial responses to acetylchOline (Ach) in humans 
have not previously been possible. We performed in vivo 
catheter-based high frequency intravascular ultrasound of the 
distal pulmonary arteries in 20 patients, g with HF and PH (Group 
2), 5 with HF but normal PA pressure (Group 3). and six 
control(C)(Group 1) patients with normal PA pressure and normal 
left ventricular systolic function during Incremental doses of 
acetylcholine(AcH)(10", 1 0", and 1 0" molar) before and after 
pretreatment with methylene blue(MB). Pulmonary artery area 
(PAA) was measured at baseline and after each intervention. The 
percent change in PAA in response to 10" molar Ach did not differ 
between gropus (-1.6±6.7% Group 1. 1.3±3.1% Group 2 and -
2.0±3,2% Group 3. p=ns). However, when a similar low dose 
Ach Infusion was repeated following pretreatment with MB, there 
was a marked percent decrease in PAA in Group 3 (-12.5±8.1% 
Group 3 vs. 2±4.1% Group 2 & -1.8±3.9% Group 1, p<0.05 
Group 3 compared to Group 2 and 1). These results suggest that 
endothelium-dependent pulmonary vascular responses to Ach in 
heart failure are tone dependent and that a defective endothelium•
dependent vasodilatory function may explain the presence of PH 
in patients with HF. 
